Literature DB >> 29369730

Keeping Expectations in Check With Immune Checkpoint Inhibitors.

Jennifer S Temel1, Justin F Gainor1, Ryan J Sullivan1, Joseph A Greer1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29369730     DOI： 10.1200/JCO.2017.76.2146

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

Review 1.  Liver graft rejection following immune checkpoint inhibitors treatment: a review.

Authors:  Bo Hu; Xiao-Bo Yang; Xin-Ting Sang
Journal:  Med Oncol       Date:  2019-10-11       Impact factor: 3.064

2.  The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors.

Authors:  Julia Lai-Kwon; Chloe Khoo; Serigne Lo; Donna Milne; Mustafa Mohamed; Jeanette Raleigh; Kortnye Smith; Karolina Lisy; Shahneen Sandhu; Michael Jefford
Journal:  J Cancer Surviv       Date:  2019-06-04       Impact factor: 4.442

3.  Caregiver-guided pain coping skills training for patients with advanced cancer: Background, design, and challenges for the CaringPals study.

Authors:  Laura S Porter; Gregory Samsa; Jennifer L Steel; Laura C Hanson; Thomas W LeBlanc; Janet Bull; Stacy Fischer; Francis J Keefe
Journal:  Clin Trials       Date:  2019-02-19       Impact factor: 2.486

4.  Balancing the Hype with Reality: What Do Patients with Advanced Melanoma Consider When Making the Decision to Have Immunotherapy?

Authors:  Annie Wong; Alex Billett; Donna Milne
Journal:  Oncologist       Date:  2019-04-23

Review 5.  Current and Future Immunotherapy-Based Treatments for Oesophageal Cancers.

Authors:  Natalie To; Richard P T Evans; Hayden Pearce; Sivesh K Kamarajah; Paul Moss; Ewen A Griffiths
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

6.  Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies.

Authors:  Jingli Lu; Jing Yang; Yan Liang; Haiyang Meng; Junjie Zhao; Xiaojian Zhang
Journal:  Front Pharmacol       Date:  2019-12-06       Impact factor: 5.810

7.  Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer.

Authors:  Jennifer L Schehr; Nan Sethakorn; Zachery D Schultz; Camila I Hernandez; Rory M Bade; Diego Eyzaguirre; Anupama Singh; David J Niles; Leslie Henderson; Jay W Warrick; Scott M Berry; Kaitlin E Sundling; David J Beebe; Ticiana A Leal; Joshua M Lang
Journal:  Biomark Res       Date:  2022-04-25

8.  In the literature: December 2018.

Authors:  Valentina Gambardella; Tania Fleitas; Andrés Cervantes
Journal:  ESMO Open       Date:  2018-11-28

9.  Complex challenges for patients with protracted incurable cancer: an ethnographic study in a comprehensive cancer centre in the Netherlands.

Authors:  Hilde M Buiting; Marleen A C van Ark; Otto Dethmers; Emma P E Maats; Jogien A Stoker; Gabe S Sonke
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

10.  Hospice or Hospital: The Costs of Dying of Cancer in the Oncology Care Model.

Authors:  J Russell Hoverman; B Brooke Mann; Sara Phu; Philip Nelson; Jad E Hayes; Cynthia B Taniguchi; Marcus A Neubauer
Journal:  Palliat Med Rep       Date:  2020-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.